Abstract:Abstract Tyro3, Axl, and Mertk (abbreviated TAMs) comprise a family of homologous type 1 receptor tyrosine kinases (RTKs) that have been implicated as inhibitory receptors that dampen inflammation, but their roles in the pathogenesis of rheumatoid arthritis remains understudied. Here, to investigate TAMs in an inflammatory arthritis model, antibody-induced arthritis in single TAM-deficient mice (Tyro3- KO, Axl-KO, Mertk-KO) was induced by K/BxN serum injection. Subsequently, joint inflammation and cytokine levels, as well as the expression of Fcγ Rs and complement receptors were assessed in WT and TAM-deficient mice. Compared with littermate control mice, Axl −/− and Mertk −/− mice developed more severe antibody-induced arthritis, while in contrast, Tyro3 −/− mice showed diminished joint inflammation. Concomitantly, the levels of cytokines in joints of Axl −/− and Mertk −/− mice were also significantly increased, while cytokines in the Tyro3 −/− joint tissues were decreased. At the molecular and cellular level, TAMs showed distinct expression patterns, whereby monocytes expressed Axl and Mertk, but no Tyro3, while neutrophils expressed Axl and Tyro3 but little Mertk. Moreover, expression of Fcγ receptors and C5aR showed different patterns with TAMs expression, whereby FcγRIV was higher in monocytes of Axl −/− and Mertk −/− mice compared to wild-type mice, while Tyro3 −/− neutrophils showed lower expression levels of FcγRI, FcγRIII and FcγRIV. Finally, expression of C5aR was increased in Mertk −/− monocytes, and was decreased in Tyro3 −/− neutrophils. These data indicate that Axl, Mertk and Tyro3 have distinct functions in antibody-induced arthritis, due in part to the differential regulation of cytokines production, as well as expression of FcγRs and C5aR.

Research proress of TAM receptor tyrosine kinases in negatively regulating the inflammation

Tumor-Associated Macrophages in Tumor Immunity (vol <i>11</i>, <i>583084</i>, <i>2020</i>)

MicroRNA-92a Negatively Regulates Toll-like Receptor (TLR)-triggered Inflammatory Response in Macrophages by Targeting MKK4 Kinase

The Role of Macrophage TAM Receptor Family in the Acute‐to‐chronic Progression of Liver Disease: from Friend to Foe?

TAM Receptor Inhibition–Implications for Cancer and the Immune System

Age-related Changes in Expression and Signaling of TAM Receptor Inflammatory Regulators in Monocytes

The role of macrophage <scp>TAM</scp> receptor family in the acute‐to‐chronic progression of liver disease: from friend to foe?

Downregulation of TLR4 by Mir-181A Provides Negative Feedback Regulation to Lipopolysaccharide-Induced Inflammation

The Multifaceted Roles of TAM Receptors during Viral Infection

Mechanistic studies of tumor-associated macrophage immunotherapy

Progress in Tumor‐Associated Macrophages: from Bench to Bedside

Roles of Tumor-Associated Macrophages in Tumor Environment and Strategies for Targeting Therapy

Focus on negatively regulated NLRs in inflammation and cancer

Expression of TAM-R in Human Immune Cells and Unique Regulatory Function of MerTK in IL-10 Production by Tolerogenic DC

Research Progress of Intervention on Toll Like Receptor 4 Signal Transduction

Role of TL1A in Inflammatory Autoimmune Diseases: A Comprehensive Review

Immunotherapies Targeting Tumor-Associated Macrophages (TAMs) in Cancer

Receptor tyrosine kinases Tyro3, Axl, and Mertk differentially contribute to antibody-induced arthritis

Research Progress on the Role of Tumor‑associated Macrophages in Tumor Development and Their Use As Molecular Targets (Review).

TRIM Proteins in Inflammation: from Expression to Emerging Regulatory Mechanisms

TAM-targeted reeducation for enhanced cancer immunotherapy: Mechanism and recent progress